Front Page

IMed Group, a leading provider of expert services to the global medical and health technology industry, is pleased to announce the appointment of Parminder Kalle as its new Chief Commercial Officer. Parminder brings over 20 years of experience across medical devices, in vitro diagnostics (IVDs), Pharma and digital health, combining...

The inaugural East Midlands Life Sciences Summit took place this week at Charnwood Campus, Science, Innovation and Technology Park, bringing together over 150 leaders from industry, academia, and the NHS to explore how the region can help the UK deliver on its Life Sciences Vision and Strategy. Themed “Scaling for...

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The facility represents a significant expansion in Kindeva’s MDI services and will develop and test next-generation propellants (NGP) as the industry prepares to move to more...

In a significant move for the global medtech landscape, the European Commission has initiated a targeted revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR). This response to widespread calls from the medtech sector aims to streamline regulatory processes, cut costs, and expedite market...

Inaphaea BioLabs, the wholly owned translational Contract Research Organisation of ValiRx Plc, has announced a series of major initiatives over the past three months that significantly advance its role in translational cancer research, drug discovery, and personalised medicine. Under the leadership of Mark Eccleston, the recently appointed CEO of parent...

Following the delivery of its first cohort and strong demand for Cohort 2, Medilink Midlands is now welcoming applications for Cohort 3 of its venture readiness programme, the Medilink Midlands Innovation Builder (MMIB), launching in early 2026. MMIB has quickly become a valued route for health and medtech innovators to...

On Thursday 11 September, Medilink Midlands was honoured to receive the Outstanding Contribution to Life Sciences Award at the Life Sciences Gala Dinner & Awards, part of Life Sciences Week 2025 – a week-long programme of events celebrating the region’s life sciences excellence. The Gala Dinner brought together organisations and...

Medilink Midlands has celebrated another hugely successful Innovation Day, the Midlands' flagship life sciences and medtech conference and exhibition. Held on Wednesday 17 September at Villa Park, Birmingham, the event brought together over 250 delegates for a full day of sector insight, networking, exhibitions, and expert-led workshops. As part of...

WMHTC today announced a significant transition in its leadership and ownership structure. The current Executive Chair of WMHTC, David Kidney, will be stepping down, marking the end of a pivotal chapter in the organisation’s journey. Effective 1 October 2025, WMHTC will be operated under the stewardship of Medilink Midlands. This...